What the clinical evidence shows Phase 2 monotherapy trials: cagrilintide alone The Phase 2 clinical trial for cagrilintide monotherapy was published in The Lancet in 2021
Magnetic resonance enterography, originally developed for inflammatory bowel disease evaluation, demonstrates excellent performance for detecting bowel endometriosis
IV Nutrition delivers vitamins, minerals, and antioxidants directly to the bloodstream to reduce oxidative stress
Post-protocol maintenance After completing an initial protocol, some researchers use lower-frequency maintenance dosing (BPC-157 once daily or every other day, TB-500 once weekly) for an additional 4 to 6 weeks
Support for connective tissue / cartilage / bone health (emerging) Some clinics suggest it may aid cartilage repair, bone density improvements, or joint health (often when paired with other peptides)